Risk assessment of ochratoxin A in food
Ochratoxin A (OTA) in food poses a possible health concern, especially for younger consumers and infants, due to potential kidney toxicity and carcinogenicity. The margin of exposure (MOE) approach indicates a possible risk, particularly if OTA
Area of Science:
- Food safety and toxicology
- Mycotoxin analysis
- Risk assessment of food contaminants
Background:
- Ochratoxin A (OTA) is a mycotoxin produced by fungi, found in various foods, and known to cause kidney toxicity and tumors in animals.
- Recent studies have introduced uncertainty regarding the mode of action for OTA's kidney carcinogenicity.
- The European Food Safety Authority (EFSA) was requested to update its 2006 opinion on OTA in food.
Purpose of the Study:
- To update the 2006 opinion on Ochratoxin A (OTA) in food.
- To assess the health risks associated with OTA exposure in various consumer groups, including infants.
- To apply a margin of exposure (MOE) approach due to uncertainties in OTA's mode of action.
Main Methods:
- Utilized a benchmark dose lower confidence limit (BMDL 10) approach for both non-neoplastic (kidney lesions in pigs) and neoplastic (kidney tumors in rats) effects.
- Estimated chronic dietary exposure to OTA across different consumer groups and age ranges.
- Calculated MOE values by comparing estimated OTA exposures with the derived BMDL 10 values.
Main Results:
- BMDL 10 values were 4.73 μg/kg bw/day for non-neoplastic effects and 14.5 μg/kg bw/day for neoplastic effects.
- Estimated mean and 95th percentile chronic dietary exposures ranged from 0.6 to 17.8 and 2.4 to 51.7 ng/kg bw/day, respectively.
- MOEs were >200 for most consumers (low concern), but lower for high consumers in younger age groups (possible concern). MOEs were <10,000 for nearly all scenarios when compared to the neoplastic endpoint (possible concern if genotoxicity is direct).
Conclusions:
- A health-based guidance value (HBGV) was deemed inappropriate due to uncertainties in OTA's mode of action.
- The MOE approach suggests a possible health concern for specific consumer groups, particularly high consumers in younger age brackets and infants, depending on OTA's genotoxic mechanism.
- High uncertainty exists in the assessment, and the estimated risk may be overestimated.
More Related Videos
08:56Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
Published on: November 22, 2024
12:02Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
Published on: August 8, 2020
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Teratogenicity
Taste Buds and Receptors
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
